| 2017-04-20 19:54:00|
ONTX 19:54 04/20 04/20/17
Onconova files to sell common stock, no amount given
Onconova intends to offer and sell shares of its common stock in an underwritten public offering. Onconova intends to use the net proceeds to support development of rigosertib for treatment in higher risk myelodysplastic syndromes. Laidlaw & Company is acting as sole book-running manager.